CK Life Sciences Int'l. (Holdings) マネジメント
マネジメント 基準チェック /24
CK Life Sciences Int'l. (Holdings)の CEO はLance Richard Lee Yuenで、 Sep2024年に任命され、 の在任期間は 1 年未満です。 は、会社の株式の0.024%を直接所有しており、その価値はHK$ 1.01M 。経営陣と取締役会の平均在任期間はそれぞれ14.2年と6年です。
主要情報
Lance Richard Lee Yuen
最高経営責任者
n/a
報酬総額
| CEO給与比率 | n/a |
| CEO在任期間 | less than a year |
| CEOの所有権 | 0.02% |
| 経営陣の平均在職期間 | 14.2yrs |
| 取締役会の平均在任期間 | 6yrs |
経営陣の近況
Recent updates
CK Life Sciences Int'l., (Holdings) Inc.'s (HKG:775) Share Price Boosted 34% But Its Business Prospects Need A Lift Too
Oct 04
There's No Escaping CK Life Sciences Int'l., (Holdings) Inc.'s (HKG:775) Muted Revenues Despite A 32% Share Price Rise
May 03CK Life Sciences Int'l. (Holdings)'s (HKG:775) Anemic Earnings Might Be Worse Than You Think
Apr 25CK Life Sciences Int'l. (Holdings) (HKG:775) Use Of Debt Could Be Considered Risky
Mar 26Here's Why CK Life Sciences Int'l. (Holdings) (HKG:775) Can Manage Its Debt Responsibly
Sep 27Does CK Life Sciences Int'l. (Holdings) (HKG:775) Have A Healthy Balance Sheet?
Sep 16Estimating The Intrinsic Value Of CK Life Sciences Int'l., (Holdings) Inc. (HKG:775)
Aug 21These 4 Measures Indicate That CK Life Sciences Int'l. (Holdings) (HKG:775) Is Using Debt Extensively
Apr 14CK Life Sciences Int'l., (Holdings) Inc. (HKG:775) Delivered A Weaker ROE Than Its Industry
Mar 18If You Had Bought CK Life Sciences Int'l. (Holdings) (HKG:775) Shares Five Years Ago You'd Have Earned 45% Returns
Feb 01
What Kind Of Shareholders Hold The Majority In CK Life Sciences Int'l., (Holdings) Inc.'s (HKG:775) Shares?
Jan 04CK Life Sciences Int'l. (Holdings) (HKG:775) Has A Somewhat Strained Balance Sheet
Dec 09We Wouldn't Rely On CK Life Sciences Int'l. (Holdings)'s (HKG:775) Statutory Earnings As A Guide
Nov 18CEO（最高経営責任者
Lance Richard Lee Yuen (59 yo)
less than a year
在職期間
Mr. Lance Richard Lee Yuen is Executive Director, Vice President & Chief Executive Officer of CK Life Sciences Int'l. (Holdings) Inc. from September 20, 2024. Mr. Yuen joined the Group in September 2024.M...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Executive Chairman | 22.6yrs | HK$125.00k | 0.023% HK$ 990.0k | |
| President & Executive Director | 22.4yrs | HK$2.58m | 0.065% HK$ 2.7m | |
| Senior VP | no data | HK$1.60m | 0.023% HK$ 990.0k | |
| VP, Chief Scientific Officer & Executive Director | 6yrs | HK$6.13m | データなし | |
| VP, CEO & Executive Director | less than a year | データなし | 0.024% HK$ 1.0m | |
| Chief Financial Officer | no data | データなし | データなし | |
| Chief Operating Officer of Global Operations | no data | データなし | データなし | |
| Senior Manager of Human Resources & Administration | no data | データなし | データなし | |
| General Counsel | no data | データなし | データなし | |
| Vice President of Corporate Development | no data | データなし | データなし | |
| Chief Corporate Affairs Officer | no data | データなし | データなし | |
| Company Secretary | 22.8yrs | データなし | データなし |
14.2yrs
平均在職期間
59.5yo
平均年齢
経験豊富な経営陣: 775の経営陣は経験豊富で経験豊富です（平均在職期間は14.2年）。
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Executive Chairman | 22.6yrs | HK$125.00k | 0.023% HK$ 990.0k | |
| President & Executive Director | no data | HK$2.58m | 0.065% HK$ 2.7m | |
| Senior VP | no data | HK$1.60m | 0.023% HK$ 990.0k | |
| VP, Chief Scientific Officer & Executive Director | 6yrs | HK$6.13m | データなし | |
| VP, CEO & Executive Director | less than a year | データなし | 0.024% HK$ 1.0m | |
| Independent Non-Executive Director | 22.4yrs | HK$100.00k | 0.0021% HK$ 88.0k | |
| Co-Chairman of Vitaquest International LLC | no data | データなし | データなし | |
| Non-Executive Director | 22.6yrs | HK$75.00k | 0.011% HK$ 461.8k | |
| Deputy Chairman | less than a year | HK$14.79m | 0.023% HK$ 990.0k | |
| Independent Non-executive Director | 9.7yrs | HK$155.00k | データなし | |
| Independent Non-Executive Director | 4.3yrs | HK$205.00k | データなし | |
| Independent Non-Executive Director | 5.4yrs | HK$205.00k | データなし |
6.0yrs
平均在職期間
70yo
平均年齢
経験豊富なボード: 775の 取締役会 は 経験豊富 であると考えられます ( 6年の平均在任期間)。